Table 1

Baseline characteristics of 43 145 men with a first myocardial infarction(MI) during 2007 to 2013 in sweden in relation to treatment for erectile dysfunction

All menNo treatment for erectile dysfunctionTreatment for erectile dysfunction
Men, number43 14540 0773068
Age, mean (SD)64 (10)64 (10)61 (9.0)
Heart failure, n (%)873 (2.0)854 (2.1)19 (0.6)
Diabetes, n (%)5392 (13)5083 (13)309 (10)
COPD677 (1.6)652 (1.6)25 (0.8)
Stroke, n (%)2505 (5.8)2407 (6.0)98 (3.2)
PAD, n (%)238 (0.6)230 (0.6)8 (0.3)
Active cancer, n (%)545 (1.3)522 (1.3)23 (0.8)
Betablockers, n (%)9285 (22)8790 (22)495 (16)
Statins, n (%)7240 (17)6827 (17)413 (13)
ACE/ARB, n (%)11 286 (26)10 585 (26)701 (23)
Nitrates, n (%)2398 (5.6)2291 (5.7)107 (3.5)
Thiazides, n (%)7804 (18)7397 (18)407 (13)
Platelet inhibitors, n (%)7938 (18)7553 (19)385 (13)
Opioids, n (%)3268 (7.6)3035 (7.6)233 (7.6)
SSRI, n (%)1894 (4.4)1800 (4.5)94 (3.1)
Neuroleptics, n (%)639 (1.5)618 (1.5)21 (0.7)
CCB, n (%)6986 (16)6610 (16)376 (12)
This table includes only patients who survived to 30 days after the index-date.
COPD, chronic obstructive pulmonary disease; PAD, peripheral artery disease; ACE/ARB, angiotensin-converting-enzyme inhibitors/angiotensinogen-receptor-blockers; SSRI, selective serotonin reuptake inhibitors; CCB, calcium channel blockers.